Biohit Oyj is a Finnish public limited company whose Series B share is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group.
Biohit Group is hereafter abbreviated as ‘Biohit’. Biohit is headquartered in Helsinki and it has subsidiaries in Italy and the UK. Biohit also participates in Chinese Joint Venture.
Biohit’s administration complies with current legislation, standards and recommendations concerning public listed companies, the regulations of NASDAQ OMX Helsinki Oy, and Biohit Oyj’s Articles of Association. As of October 1, 2010, Biohit Oyj complies with the Finnish Corporate Governance Code issued on June 15, 2010 by the Securities Market Association.
- Shareholder Meeting
- Biohit’s Corporate Governance Statements
- Articles of Association
- Board of Directors
- Board Meetings
- President and CEO
- Other Management
- Remuneration for members of the Management Team
- Renumeration policy
- Internal Control and Risk Management
- Biohit Oyj’s Optio Schemes I 2013 and II 2013
- Insider Regulations
- Disclosure Policy